Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
96
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Diabetes mellitus predicts inferior survival in diffuse large B-cell lymphoma: a propensity score-matched analysis

Rui Gao1 Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, People’s Republic of China
,
Jin-Hua Liang2 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, People’s Republic of China
,
Tian-Shuo Man2 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, People’s Republic of China
,
Li Wang2 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, People’s Republic of China
,
Hua-Yuan Zhu2 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, People’s Republic of China
,
Wei Wu2 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, People’s Republic of China
,
Lei Fan2 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, People’s Republic of China
,
Jian-Yong Li2 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, People’s Republic of China
,
Tao Yang1 Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing 210029, People’s Republic of ChinaCorrespondence[email protected]
&
Wei Xu2 Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 2849-2870 | Published online: 09 Apr 2019

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Weiling Zhou, Weijing Li, Cuiying He, Ruijuan Ma, Qian Gao, Yuan Wang, Lei Feng & Lihong Liu. (2022) Influence of Hyperglycemia on the Prognosis of Patients with Diffuse Large B-Cell Lymphoma. Diabetes, Metabolic Syndrome and Obesity 15, pages 2039-2049.
Read now
Bria J Rice, Matthew R Buras, Heidi E Kosiorek, Kyle E Coppola, Shailja B Amin, Patricia M Verona, Curtiss B Cook & Nina J Karlin. (2021) Survival and Glycemic Control in Patients with Coexisting Lymphoma and Diabetes: A Case–Control Analysis. Future Science OA 7:1.
Read now
Jelena Jelicic, Thomas Stauffer Larsen, Henrik Frederiksen, Bosko Andjelic, Milos Maksimovic & Zoran Bukumiric. (2020) Statistical Challenges in Development of Prognostic Models in Diffuse Large B-Cell Lymphoma: Comparison Between Existing Models – A Systematic Review. Clinical Epidemiology 12, pages 537-555.
Read now

Articles from other publishers (6)

Weiling Zhou, Qian Gao, Cuiying He, Lianjing Wang, Yuan Wang, Lei Feng, Weijing Li, Wei Liu, Ruijuan Ma & Lihong Liu. (2023) Association Between Polymorphism in Diabetes Susceptibility Gene Insulin-Like Growth Factor 2mRNA–Binding Protein 2 and Risk of Diffuse Large B-Cell Lymphoma. Clinical Medicine Insights: Oncology 17.
Crossref
Akiva Diamond, Sabarish Ayyappan, Shufen Cao, Nour Tashtish, Kirsten Boughan, Brenda Cooper, PingFu Fu & Paolo F. Caimi. (2022) Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B‐cell lymphoma and treated with anthracyclines. Hematological Oncology 40:4, pages 626-636.
Crossref
Shama Jaswal, Vanessa Sanders, Priyanka Pullarkat, Stephanie Teja, Amber Salter, Marcus P. Watkins, Norman Atagu, Daniel R. Ludwig, Joyce Mhlanga, Vincent M. Mellnick, Linda R. Peterson, Nancy L. Bartlett, Brad S. Kahl, Todd A. Fehniger, Armin Ghobadi, Amanda F. Cashen, Neha Mehta-Shah & Joseph E. Ippolito. (2022) Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma. Cancers 14:12, pages 2932.
Crossref
Will Harris, Edward J. Bataillard, Yoonha Choi, Tarec C. El-Galaly, Vaikunth Cuchelkar, Carsten Henneges, Antonia Kwan, Daniel J. Schneider, Joseph N. Paulson & Tina G. Nielsen. (2022) TRAIL Score: A Simple Model to Predict Immunochemotherapy Tolerability in Patients With Diffuse Large B-Cell Lymphoma. JCO Clinical Cancer Informatics:6.
Crossref
Zhen Han, Hong Xu, Meiqing Zhao, Fanjing Jing, Hongwei Xue & Shuxin Xiao. (2022) Diabetes and the Prognosis in Patients With Non-Hodgkin Lymphoma: A Meta-analysis of Cohort Studies. Clinical Lymphoma Myeloma and Leukemia 22:2, pages e77-e88.
Crossref
Lei Wang, ZhiQiang Zhao, YanHong Luo, HongMei Yu, ShuQing Wu, XiaoLu Ren, ChuChu Zheng & XueQian Huang. (2020) Classifying 2-year recurrence in patients with dlbcl using clinical variables with imbalanced data and machine learning methods. Computer Methods and Programs in Biomedicine 196, pages 105567.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.